OpenFilings
Form
8-K
Report Period
2024-01-24
Date Filed
2024-01-24
Time Filed
16:00:27
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
CERTIFICATE OF DESIGNATION OF SENIOR A JUNIOR PREFERRED STOCK OF BELLICUM PHARMA
AMENDMENT TO AMENDED AND RESTATED BYLAWS OF BELLICUM PHARMACEUTICALS, INC., EFFE
Filing on SEC Edgar